Zobrazeno 1 - 10
of 37
pro vyhledávání: '"cancer immune cell therapy"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/cbf3bc2405d848018dc690418a7bbdb4
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Chimeric antigen receptor (CAR) T cell therapy has effectively complemented the treatment of advanced relapsed and refractory hematological cancers. The remarkable achievements of CD19- and BCMA-CAR T therapies have raised high expectations within th
Externí odkaz:
https://doaj.org/article/f04ddcfc676e402e870c7f56755056a4
Autor:
Sarah Staudt, Kai Ziegler-Martin, Alexander Visekruna, John Slingerland, Roni Shouval, Michael Hudecek, Marcel van den Brink, Maik Luu
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The opportunities genetic engineering has created in the field of adoptive cellular therapy for cancer are accelerating the development of novel treatment strategies using chimeric antigen receptor (CAR) and T cell receptor (TCR) T cells. The great s
Externí odkaz:
https://doaj.org/article/c3512a04084f460ca535deb941c644e6
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/29950a00efc54f9d82c5676ea35d1370
Autor:
Cooper J. Sailer, Yeonsun Hong, Ankit Dahal, Allison T. Ryan, Sana Mir, Scott A. Gerber, Patrick M. Reagan, Minsoo Kim
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Chimeric antigen receptor (CAR)-T cell therapy has emerged as a promising treatment option for several hematologic cancers. However, efforts to achieve the same level of therapeutic success in solid tumors have largely failed mainly due to CAR-T cell
Externí odkaz:
https://doaj.org/article/b1273da7a6c9425a94ada34badec2d9e
Autor:
Zeinab Ghazvinian, Shahrokh Abdolahi, Samaneh Tokhanbigli, Shadi Tarzemani, Andrea Piccin, Mohammad Reza Zali, Javad Verdi, Kaveh Baghaei
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
Natural killer cells are members of the innate immune system and promote cytotoxic activity against tumor or infected cells independently from MHC recognition. NK cells are modulated by the expression of activator/inhibitory receptors. The ratio of t
Externí odkaz:
https://doaj.org/article/97fe35c89bad4a70be1990168bcf506b
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Chimeric antigen receptors (CAR) T cells (CAR-T) mark a significant step towards producing safe and effective personal anticancer treatments. CAR-T strategies engineers the T cells from the patients to allow specific binding to a tumour-specific anti
Externí odkaz:
https://doaj.org/article/fa55623c9168459dbad4f30d2ced1cca
Autor:
Rio Sugimura, Clement Yisai Wang
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Innate Lymphoid Cells (ILCs) are an elusive type of innate immune cell that was only discovered recently. Their tissue residency and dependency makes them a niche group of cells that bridge the adaptive and innate immune system. The nomenclature and
Externí odkaz:
https://doaj.org/article/3de6a29a4ffa4cfaae3ef841614ebbe3
Autor:
Md Faqrul Hasan, Tayler J. Croom-Perez, Jeremiah L. Oyer, Thomas A. Dieffenthaller, Liza D. Robles-Carrillo, Jonathan E. Eloriaga, Sanjana Kumar, Brendan W. Andersen, Alicja J. Copik
Publikováno v:
Cancers; Volume 15; Issue 10; Pages: 2712
Treatments targeting TIGIT have gained a lot of attention due to strong preclinical and early clinical results, particularly with anti-PD-(L)1 therapeutics. However, this combination has failed to meet progression-free survival endpoints in phase III
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::290eca34a9ebaaa0d3a6549c6abaebe3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.